China authorises CoronaVac COVID-19 vaccine for children above 3 yrs

By: |
June 06, 2021 3:31 PM

China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.

China has approved about five of its vaccines for emergency use.

China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said. “But when the vaccine will be put into (emergency) use, and starting from what age in the group has yet to be decided,” he was quoted as saying by the state-run Global Times on Sunday.

Sinovac has finished the Phrase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved that the vaccine is as safe and efficient as it is for adults, Yin told China Central Television (CCTV) in an interview on Friday. The Wold Health Organisation (WHO) has granted approval on June 1 to China’s second COVID-19 vaccine, Sinovac, which was expected to strengthen China’s vaccine diplomacy.

Earlier, WHO granted a similar approval to China’s Sinopharm. Besides administering the vaccines at home, China has been donating and exporting the vaccines to number of countries as part of its vaccine diplomacy. China’s National Health Commission said on Sunday that over 763 million doses of COVID-19 vaccines had been administered across China so far.

For its part, China has approved about five of its vaccines for emergency use. China has offered 10 million vaccine doses to COVAX facility which is WHO backed initiative to provide vaccines to developing countries.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Serum Institute seeks DCGI’s approval for Covishield as booster dose
2Mandaviya tables Assisted Reproductive Technology Bill for regulation of clinics
3Omicron scare: UP Government orders for genome sequencing and 8-days home quarantine for international passengers